Joseph A. Costa D.O. Professor & Assistant Dean for Clinical Informatics; Interim Program Director, Urology Residency; Clerkship Director Department: Department of Urology Business Phone: (904) 244-7340 Business Email: Joseph.costa@jax.ufl.edu Appointments and Locations About Joseph A. Costa Dr. Costa is an internationally renowned reconstructive urologist specializing in pelvic urologic disorders. He is specially trained in treating patients with spinal cord injuries, multiple sclerosis and other neurological conditions. Show More Board Certifications UrologyFemale Pelvic Medicine and Reconstructive Surgery Show More Clinical Profile Specialties Neurourology & Reconstructive SurgeryUrology Interests Clinical Special Interests: Male and female incontinence; reconstructive surgery; female pelvic organ prolapse (cystocele, rectocele, uterine prolapse); male urethral stricture disease; spinal cord injury and neurourology; multiple sclerosis; neuropathic voiding dysfunction; transurethral needle ablation of the prostate; urodynamic services Show More Publications 2022Estimated Glomerular Filtration Rate Predicts Complications Following Artificial Urinary Sphincter Surgery.Urology.168():208-215[DOI] 10.1016/j.urology.2022.06.019.[PMID] 35779711.PubMed·Publisher's Site2021An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.Journal of endourology.35(4):409-416[DOI] 10.1089/end.2020.0739.[PMID] 32962442.16 citations·PubMed·Publisher's Site2021Intracorporeal versus extracorporeal urinary diversion following robot-assisted radical cystectomy: a meta-analysis, cumulative analysis, and systematic review.Journal of robotic surgery.15(3):321-333[DOI] 10.1007/s11701-020-01174-4.[PMID] 33222043.7 citations·PubMed·Publisher's Site2021Pathology grade influences competing mortality risks in elderly men with prostate cancer.Urologic oncology.39(8):493.e1-493.e7[DOI] 10.1016/j.urolonc.2020.12.004.[PMID] 33353870.1 citations·PubMed·Publisher's Site2020A Systematic Review and Meta-Analysis of Methods Used to Reduce Infectious Complications Following Transrectal Prostate Biopsy.Urology.144():21-27[DOI] 10.1016/j.urology.2020.06.005.[PMID] 32569659.2 citations·PubMed·Publisher's Site2020Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.Urologic oncology.38(11):826-834[DOI] 10.1016/j.urolonc.2020.03.022.[PMID] 32605736.19 citations·PubMed·Publisher's Site2019Serum Testosterone 60 Months after Passive-Scatter Proton Therapy for Localized Prostate Cancer.Cancer investigation.37(2):85-89[DOI] 10.1080/07357907.2019.1565766.[PMID] 30836776.5 citations·PubMed·Publisher's Site2018Bilateral distal ureteral transection in the setting of blunt trauma.Trauma surgery & acute care open.3(1):e000175-[DOI] 10.1136/tsaco-2018-000175.[PMID] 30023435.PubMed·Publisher's Site2018Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker Placement.American journal of clinical oncology.41(12):1243-1245[DOI] 10.1097/COC.0000000000000454.[PMID] 29727310.PubMed·Publisher's Site2016Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate Cancer.International journal of particle therapy.3(1):21-26[DOI] 10.14338/IJPT-16-00007.1.[PMID] 31772972.2 citations·PubMed·Publisher's Site2016Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate Cancer.International journal of particle therapy.2(4):518-524[DOI] 10.14338/IJPT-15-00034.1.[PMID] 30079368.2 citations·PubMed·Publisher's Site2015Hemorrhagic radiation cystitis.American journal of clinical oncology.38(3):331-6[DOI] 10.1097/COC.0000000000000016.[PMID] 24322335.23 citations·PubMed·Publisher's Site2014Five-year outcomes from 3 prospective trials of image-guided proton therapy for prostate cancer.International journal of radiation oncology, biology, physics.88(3):596-602[DOI] 10.1016/j.ijrobp.2013.11.007.[PMID] 24521677.69 citations·PubMed·Publisher's Site2014Warty Condylomatous Squamous Cell Carcinoma of the Penis in a 19-Year-Old.Urology case reports.2(3):79-81[DOI] 10.1016/j.eucr.2014.03.002.[PMID] 26955552.2 citations·PubMed·Publisher's Site2013Catheter length preference in wheelchair-using men who perform routine clean intermittent catheterization.Spinal cord.51(10):772-5[DOI] 10.1038/sc.2013.76.[PMID] 23896665.6 citations·PubMed·Publisher's Site2013Early Gastrointestinal Toxicity Outcomes From a Prospective Trial of Accelerated Hypofractionation With Proton Therapy for Prostate CancerInternational Journal of Radiation Oncology Biology Physics.87():S154-[DOI] .[PMID] .PubMed·Publisher's Site2013Five-Year Outcomes of Proton Therapy in Localized Prostate Cancer On 3 Prospective Trials for Low-, Intermediate-, and High-Risk Prostate CancerInternational Journal of Radiation Oncology Biology Physics.87():S155-[DOI] .[PMID] .PubMed·Publisher's Site2013Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppression.Acta oncologica (Stockholm, Sweden).52(3):492-7[DOI] 10.3109/0284186X.2013.767983.[PMID] 23477360.13 citations·PubMed·Publisher's Site2013Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trials.Acta oncologica (Stockholm, Sweden).52(3):463-9[DOI] 10.3109/0284186X.2013.764467.[PMID] 23477359.16 citations·PubMed·Publisher's Site2012Catheter Length Preference in Wheelchair Bound Male Patients Who Perform Clean Intermittent Catheterization.Neurourology and Urodynamics.31():773-774[DOI] .[PMID] .PubMed·Publisher's Site2012Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer.International journal of radiation oncology, biology, physics.82(1):213-21[DOI] 10.1016/j.ijrobp.2010.09.024.[PMID] 21093164.74 citations·PubMed·Publisher's Site2012Early Patterns of Failure in a Prospective Trial of Concomitant Docetaxel and Proton Therapy for High-Risk Prostate CancerInternational Journal of Radiation Oncology Biology Physics.84():S92-[DOI] .[PMID] .PubMed·Publisher's Site2012Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger.Cancer.118(18):4619-26[DOI] 10.1002/cncr.27398.[PMID] 22253020.41 citations·PubMed·Publisher's Site2012Hypofractionated Proton Radiation Therapy for Low- And, Intermediate-Risk Prostate Cancer Is Not Associated With Post-Treatment Testosterone SuppressionInternational Journal of Radiation Oncology Biology Physics.84():S375-[DOI] .[PMID] .PubMed·Publisher's Site2012Incidence of New Onset Pelvic Organ Prolapse After Repair of Other Segment in a Prospective Longitudinal Database. Topic: Reconstructive Surgery, Pelvic Organ Prolapse Or Urogenitcal ProlapseNeurourology and Urodynamics.31():856-[DOI] .[PMID] .PubMed·Publisher's Site2012Patient-Reported Quality of Life Following Treatment of Prostate Cancer With Proton TherapyInternational Journal of Radiation Oncology Biology Physics.84():S213-[DOI] .[PMID] .PubMed·Publisher's Site2012Proton radiotherapy for prostate cancer is not associated with post-treatment testosterone suppression.International journal of radiation oncology, biology, physics.82(3):1222-6[DOI] 10.1016/j.ijrobp.2010.12.025.[PMID] 21570206.20 citations·PubMed·Publisher's Site2012Urethral catheterization facilitates preradiation fiducial marker placement in postprostatectomy patients.Journal of endourology.26(5):467-8[DOI] 10.1089/end.2011.0558.[PMID] 22141439.1 citations·PubMed·Publisher's Site2011Patient-Reported Sexual Function Following Proton Therapy for Prostate Cancer in Men Age <= 60 YearsInternational Journal of Radiation Oncology Biology Physics.81():S414-[DOI] .[PMID] .PubMed·Publisher's Site2011Percutaneous intervention of large bladder calculi in neuropathic voiding dysfunction.International braz j urol : official journal of the Brazilian Society of Urology.37(5):636-41[DOI] .[PMID] 22099276.2 citations·PubMed·Publisher's Site2010Early Outcomes Following Proton Therapy for Prostate Cancer in Men 55 Years Old and YoungerInternational Journal of Radiation Oncology Biology Physics.78():S373-S374[DOI] .[PMID] .PubMed·Publisher's Site2010Risk of Hip and Femoral Neck Fractures Following Proton Therapy for Prostate CancerInternational Journal of Radiation Oncology Biology Physics.78():S192-S193[DOI] .[PMID] .PubMed·Publisher's Site2006Combination of oral tramadol, acetaminophen and 1% lidocaine induced periprostatic nerve block for pain control during transrectal ultrasound guided biopsy of the prostate: a prospective, randomized, controlled trial.The Journal of urology.176(4 Pt 1):1372-5[DOI] .[PMID] 16952635.22 citations·PubMed·Publisher's Site Show More Office Information Academic Office 3rd Floor, Faculty Clinic653 West 8th Street, FC12Jacksonville, FL 32209(904) 244-7340 Joseph.costa@jax.ufl.edu Administrative Manager Sammie Adkins(904) 244-7340sammie.adkins@jax.ufl.edu Medical Student Office 3rd Floor, Faculty Clinic653 West 8th StreetJacksonville, FL 32209Phone: (904) 244-7340Fax: (904) 244-7422 Joseph.costa@jax.ufl.edu Clerkship Coordinator Sammie Adkins(904) 244-7340sammie.adkins@jax.ufl.edu Show More Education Medical Degree1991 · College of Osteopathic Medicine of The Pacific, Pomona, CA, USAUrology Residency1999 · Naval Medical Center (Portsmouth), Portsmouth, VA, USANeurourology & Reconstructive Surgery Fellowship2000 · University of Iowa Hospitals and Clinics, Iowa City, IA, USA Show More News July 10, 2019 Synchronized surgeries for a high-risk pregnancy delivery at UF Health Jacksonville June 27, 2019 14 UF COMJ faculty members receive promotions for 2019-2020 July 6, 2018 K.C. Balaji, MD, joins UF Health as new chair of urology January 19, 2018 Rapid relief for patients with enlarged prostates March 10, 2017 Compassion and research are the foundation for UF Health’s Comprehensive MS Program